
LOCUS       NP_037163                515 aa            linear   ROD 21-JUN-2020
DEFINITION  synaptic vesicular amine transporter [Rattus norvegicus].
ACCESSION   NP_037163
VERSION     NP_037163.1
DBSOURCE    REFSEQ: accession NM_013031.1
KEYWORDS    RefSeq.
SOURCE      Rattus norvegicus (Norway rat)
  ORGANISM  Rattus norvegicus
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
            Muroidea; Muridae; Murinae; Rattus.
REFERENCE   1  (residues 1 to 515)
  AUTHORS   Yaffe D, Vergara-Jaque A, Forrest LR and Schuldiner S.
  TITLE     Emulating proton-induced conformational changes in the vesicular
            monoamine transporter VMAT2 by mutagenesis
  JOURNAL   Proc. Natl. Acad. Sci. U.S.A. 113 (47), E7390-E7398 (2016)
   PUBMED   27821772
  REMARK    GeneRIF: Study identify mutants that alter the nature of the
            conformational equilibrium and mimic the protonated state of VMAT2.
            These mutants eliminate the requirement for a proton gradient
            normally necessary for reserpine binding and for reserpine
            inhibition of tetrabenazine binding.
REFERENCE   2  (residues 1 to 515)
  AUTHORS   Wang L, Kang Y, Zhang G, Zhang Y, Cui R, Yan W, Tan H, Li S, Wu B,
            Cui H and Shi G.
  TITLE     Deficits in coordinated motor behavior and in nigrostriatal
            dopaminergic system ameliorated and VMAT2 expression up-regulated
            in aged male rats by administration of testosterone propionate
  JOURNAL   Exp. Gerontol. 78, 1-11 (2016)
   PUBMED   26956479
  REMARK    GeneRIF: Up-regulation of VMAT2 expression in aged male rats
            following chronic testosterone propionate treatment might be
            involved in the maintenance of dopaminergic function of the
            nigrostriatal dopaminergic system in aged male rats.
REFERENCE   3  (residues 1 to 515)
  AUTHORS   Pan X, Guo X, Xiong F, Cheng G, Lu Q and Yan H.
  TITLE     Acrylamide increases dopamine levels by affecting dopamine
            transport and metabolism related genes in the striatal dopaminergic
            system
  JOURNAL   Toxicol. Lett. 236 (1), 60-68 (2015)
   PUBMED   25943760
  REMARK    GeneRIF: Data suggest that expression of Vmat2 and Dat1 (dopamine
            transporter 1) in dopaminergic neurons in striatum can be
            down-regulated by dietary factors (here, ingestion of acrylamide, a
            food contaminant created by heating starchy foods).
REFERENCE   4  (residues 1 to 515)
  AUTHORS   Choi WS, Kim HW and Xia Z.
  TITLE     JNK inhibition of VMAT2 contributes to rotenone-induced oxidative
            stress and dopamine neuron death
  JOURNAL   Toxicology 328, 75-81 (2015)
   PUBMED   25496994
  REMARK    GeneRIF: Rotenone induces dopamine neuron death through a series of
            sequential events including microtubule destabilization, JNK3
            activation, VMAT2 inhibition, accumulation of cytosolic dopamine,
            and generation of ROS.
REFERENCE   5  (residues 1 to 515)
  AUTHORS   Lizarraga LE, Cholanians AB, Phan AV, Herndon JM, Lau SS and Monks
            TJ.
  TITLE     Vesicular monoamine transporter 2 and the acute and long-term
            response to 3,4-(+/-)-methylenedioxymethamphetamine
  JOURNAL   Toxicol. Sci. 143 (1), 209-219 (2015)
   PUBMED   25370842
  REMARK    GeneRIF: Data suggest the involvement of VMAT2 in the
            thermoregulatory, behavioral, and neurotoxic effects of MDMA.
REFERENCE   6  (residues 1 to 515)
  AUTHORS   Nirenberg MJ, Chan J, Liu Y, Edwards RH and Pickel VM.
  TITLE     Ultrastructural localization of the vesicular monoamine
            transporter-2 in midbrain dopaminergic neurons: potential sites for
            somatodendritic storage and release of dopamine
  JOURNAL   J. Neurosci. 16 (13), 4135-4145 (1996)
   PUBMED   8753875
REFERENCE   7  (residues 1 to 515)
  AUTHORS   Dimaline R and Struthers J.
  TITLE     Expression and regulation of a vesicular monoamine transporter in
            rat stomach: a putative histamine transporter
  JOURNAL   J. Physiol. (Lond.) 490 (Pt 1), 249-256 (1996)
   PUBMED   8745292
REFERENCE   8  (residues 1 to 515)
  AUTHORS   Nirenberg MJ, Liu Y, Peter D, Edwards RH and Pickel VM.
  TITLE     The vesicular monoamine transporter 2 is present in small synaptic
            vesicles and preferentially localizes to large dense core vesicles
            in rat solitary tract nuclei
  JOURNAL   Proc. Natl. Acad. Sci. U.S.A. 92 (19), 8773-8777 (1995)
   PUBMED   7568015
REFERENCE   9  (residues 1 to 515)
  AUTHORS   Erickson JD, Eiden LE and Hoffman BJ.
  TITLE     Expression cloning of a reserpine-sensitive vesicular monoamine
            transporter
  JOURNAL   Proc. Natl. Acad. Sci. U.S.A. 89 (22), 10993-10997 (1992)
   PUBMED   1438304
REFERENCE   10 (residues 1 to 515)
  AUTHORS   Liu Y, Peter D, Roghani A, Schuldiner S, Prive GG, Eisenberg D,
            Brecha N and Edwards RH.
  TITLE     A cDNA that suppresses MPP+ toxicity encodes a vesicular amine
            transporter
  JOURNAL   Cell 70 (4), 539-551 (1992)
   PUBMED   1505023
COMMENT     PROVISIONAL REFSEQ: This record has not yet been subject to final
            NCBI review. The reference sequence was derived from L00603.1.
            
            Summary: transports N-methyl-4-phenylpyridinium (MPP+), a
            neurotoxin metabolite associated with Parkinson's disease [RGD, Feb
            2006].
            
            Publication Note:  This RefSeq record includes a subset of the
            publications that are available for this gene. Please see the Gene
            record to access additional publications.
            
            ##Evidence-Data-START##
            Transcript exon combination :: L00603.1 [ECO:0000332]
            RNAseq introns              :: single sample supports all introns
                                           SAMD00052296, SAMD00052297
                                           [ECO:0000348]
            ##Evidence-Data-END##
FEATURES             Location/Qualifiers
     source          1..515
                     /organism="Rattus norvegicus"
                     /db_xref="taxon:10116"
                     /chromosome="1"
                     /map="1q55"
     Protein         1..515
                     /product="synaptic vesicular amine transporter"
                     /note="VAT2; monoamine transporter; vesicular amine
                     transporter 2; solute carrier family 18 member 2; solute
                     carrier family 18 (vesicular monoamine), member 2; Solute
                     carrier family 18 A2 (vesicular monoamine transporter 2);
                     solute carrier family 18 (vesicular monoamine
                     transporter), member 2"
                     /calculated_mol_wt=55464
     Site            21..41
                     /site_type="transmembrane region"
                     /note="propagated from UniProtKB/Swiss-Prot (Q01827.2)"
     Site            56
                     /site_type="glycosylation"
                     /note="N-linked (GlcNAc...) asparagine.
                     /evidence=ECO:0000255; propagated from
                     UniProtKB/Swiss-Prot (Q01827.2)"
     Site            80
                     /site_type="glycosylation"
                     /note="N-linked (GlcNAc...) asparagine.
                     /evidence=ECO:0000255; propagated from
                     UniProtKB/Swiss-Prot (Q01827.2)"
     Site            81
                     /site_type="glycosylation"
                     /note="N-linked (GlcNAc...) asparagine.
                     /evidence=ECO:0000255; propagated from
                     UniProtKB/Swiss-Prot (Q01827.2)"
     Site            89
                     /site_type="glycosylation"
                     /note="N-linked (GlcNAc...) asparagine.
                     /evidence=ECO:0000255; propagated from
                     UniProtKB/Swiss-Prot (Q01827.2)"
     Site            111
                     /site_type="glycosylation"
                     /note="N-linked (GlcNAc...) asparagine.
                     /evidence=ECO:0000255; propagated from
                     UniProtKB/Swiss-Prot (Q01827.2)"
     Region          131..438
                     /region_name="MFS_1"
                     /note="Major Facilitator Superfamily; pfam07690"
                     /db_xref="CDD:284993"
     Site            131..151
                     /site_type="transmembrane region"
                     /note="propagated from UniProtKB/Swiss-Prot (Q01827.2)"
     Region          133..274
                     /region_name="2_A_01_02"
                     /note="Multidrug resistance protein; TIGR00880"
                     /db_xref="CDD:273318"
     Site            order(136,139..140,143,147..148,150..151,197..198,
                     201..202,205..206,209,222..223,226..227,233,306,309..310,
                     313..314,317,331,335,339,342,346,393,396..397,403,
                     407..408,411,422..423,426..427,430..431,434)
                     /site_type="other"
                     /note="putative substrate translocation pore"
                     /db_xref="CDD:119392"
     Site            161..181
                     /site_type="transmembrane region"
                     /note="propagated from UniProtKB/Swiss-Prot (Q01827.2)"
     Site            191..211
                     /site_type="transmembrane region"
                     /note="propagated from UniProtKB/Swiss-Prot (Q01827.2)"
     Site            221..243
                     /site_type="transmembrane region"
                     /note="propagated from UniProtKB/Swiss-Prot (Q01827.2)"
     Site            250..272
                     /site_type="transmembrane region"
                     /note="propagated from UniProtKB/Swiss-Prot (Q01827.2)"
     Site            293..312
                     /site_type="transmembrane region"
                     /note="propagated from UniProtKB/Swiss-Prot (Q01827.2)"
     Region          295..>472
                     /region_name="MFS"
                     /note="The Major Facilitator Superfamily (MFS) is a large
                     and diverse group of secondary transporters that includes
                     uniporters, symporters, and antiporters. MFS proteins
                     facilitate the transport across cytoplasmic or internal
                     membranes of a variety of...; cd06174"
                     /db_xref="CDD:119392"
     Site            330..353
                     /site_type="transmembrane region"
                     /note="propagated from UniProtKB/Swiss-Prot (Q01827.2)"
     Site            359..379
                     /site_type="transmembrane region"
                     /note="propagated from UniProtKB/Swiss-Prot (Q01827.2)"
     Site            391..411
                     /site_type="transmembrane region"
                     /note="propagated from UniProtKB/Swiss-Prot (Q01827.2)"
     Site            416..436
                     /site_type="transmembrane region"
                     /note="propagated from UniProtKB/Swiss-Prot (Q01827.2)"
     Site            442..463
                     /site_type="transmembrane region"
                     /note="propagated from UniProtKB/Swiss-Prot (Q01827.2)"
     Site            512
                     /site_type="phosphorylation"
                     /note="Phosphoserine, by CK2.
                     /evidence=ECO:0000244|PubMed:22673903,
                     ECO:0000269|PubMed:9045708; propagated from
                     UniProtKB/Swiss-Prot (Q01827.2)"
     Site            514
                     /site_type="phosphorylation"
                     /note="Phosphoserine, by CK2.
                     /evidence=ECO:0000244|PubMed:22673903,
                     ECO:0000269|PubMed:9045708; propagated from
                     UniProtKB/Swiss-Prot (Q01827.2)"
     CDS             1..515
                     /gene="Slc18a2"
                     /gene_synonym="MNAT; VMAT-2; VMAT2"
                     /coded_by="NM_013031.1:101..1648"
                     /db_xref="GeneID:25549"
                     /db_xref="RGD:3694"
ORIGIN      
        1 malsdlvllr wlrdsrhsrk lilfivflal lldnmlltvv vpiipsylys ikheknstei
       61 qttrpelvvs tsesifsyyn nstvlitgna tgtlpggqsh katstqhtva nttvpsdcps
      121 edrdllnenv qvgllfaska tvqlltnpfi glltnrigyp ipmfagfcim fistvmfafs
      181 ssyaflliar slqgigsscs svagmgmlas vytddeergn amgialggla mgvlvgppfg
      241 svlyefvgkt apflvlaalv lldgaiqlfv lqpsrvqpes qkgtplttll kdpyiliaag
      301 sicfanmgia mlepalpiwm metmcsrkwq lgvaflpasi syligtnifg ilahkmgrwl
      361 callgmvivg isilcipfak niygliapnf gvgfaigmvd ssmmpimgyl vdlrhvsvyg
      421 svyaiadvaf cmgyaigpsa ggaiakaigf pwlmtiigii diafaplcff lrsppakeek
      481 mailmdhncp iktkmytqnn vqsypigdde esesd
//

